Ligand validation:4F9V

PBD: 1-(3,4-dimethoxyphenyl)-3-[3-(1H-imidazol-1-yl)propyl]thiourea

PBD is a Ligand Of Interest in 4F9V designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4F9V_PBD_A_402	83%	44%	0.096	0.956	0.98	1.18	1	3	0	0	100%	1
4F9V_PBD_B_402	82%	34%	0.102	0.956	0.95	1.65	2	6	0	0	100%	1
4F9U_PBD_B_402	42%	21%	0.178	0.899	1.55	1.73	3	4	0	0	100%	0.7727
9FXJ_PBD_B_402	94%	69%	0.07	0.967	0.41	0.79	-	1	1	0	100%	1
3PBB_PBD_B_381	94%	22%	0.077	0.974	1.71	1.54	4	5	2	0	100%	1
4YWY_PBD_A_402	92%	31%	0.08	0.97	1.35	1.41	3	6	0	0	100%	1
4FBE_PBD_A_401	88%	31%	0.089	0.964	1.3	1.44	2	6	0	0	100%	1
3PB7_PBD_X_390	83%	32%	0.092	0.951	1.54	1.15	5	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.